DaVita
DVA
#1816
Rank
ยฃ8.69 B
Marketcap
ยฃ135.46
Share price
1.26%
Change (1 day)
43.13%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): ยฃ9.36

According to DaVita's latest financial reports the company's current EPS (TTM) is ยฃ9.43. In 2025 the company made an earnings per share (EPS) of ยฃ7.65 a decrease over its 2024 EPS that were of ยฃ8.34.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ9.3622.34%
2025ยฃ7.65-8.25%
2024ยฃ8.3444.94%
2023ยฃ5.7527.26%
2022ยฃ4.52-35.56%
2021ยฃ7.0144.1%
2020ยฃ4.8719.7%
2019ยฃ4.07540.48%
2018ยฃ0.63-76.07%
2017ยฃ2.65-19.31%
2016ยฃ3.29242.52%
2015ยฃ0.96-62.87%
2014ยฃ2.5813.43%
2013ยฃ2.288.45%
2012ยฃ2.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
ยฃ18.76 98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ9.20-2.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
ยฃ19.74 109.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
ยฃ1.60-83.04%๐Ÿ‡บ๐Ÿ‡ธ USA